Barrington Research reissued their outperform rating on shares of U.S. Physical Therapy (NYSE:USPH – Free Report) in a report published on Friday, Benzinga reports. They currently have a $108.00 price objective on the stock.
Separately, StockNews.com raised shares of U.S. Physical Therapy from a sell rating to a hold rating in a research note on Wednesday, August 21st.
Check Out Our Latest Report on USPH
U.S. Physical Therapy Stock Performance
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The business had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.76 earnings per share. As a group, equities research analysts predict that U.S. Physical Therapy will post 2.51 EPS for the current fiscal year.
U.S. Physical Therapy Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 23rd were paid a dividend of $0.44 per share. The ex-dividend date was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.11%. U.S. Physical Therapy’s dividend payout ratio is currently 143.09%.
Insider Activity at U.S. Physical Therapy
In related news, Director Kathleen A. Gilmartin acquired 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Tuesday, September 3rd. The shares were purchased at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the acquisition, the director now owns 18,904 shares in the company, valued at $1,627,445.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin bought 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was purchased at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the purchase, the director now directly owns 18,904 shares in the company, valued at $1,627,445.36. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On U.S. Physical Therapy
Hedge funds have recently bought and sold shares of the company. Canada Pension Plan Investment Board acquired a new stake in U.S. Physical Therapy during the second quarter worth approximately $28,000. Innealta Capital LLC purchased a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at approximately $30,000. Quest Partners LLC increased its position in shares of U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after purchasing an additional 337 shares during the last quarter. Northwest Bank & Trust Co acquired a new position in shares of U.S. Physical Therapy in the 4th quarter worth approximately $37,000. Finally, Quarry LP boosted its holdings in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after buying an additional 478 shares during the period.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Read More
- Five stocks we like better than U.S. Physical Therapy
- Using the MarketBeat Dividend Tax Calculator
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What is a Dividend King?
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.